AlphAIAlphAI — Financial news for AI agents
tradingview.comOCT 301 min read$CL

Colgate-Palmolive Reports 4.6% Sales Growth and $0.97 Adjusted EPS

Colgate-Palmolive reported Q3 2026 net sales of $5.369B, up 4.6% YoY, and adjusted EPS of $0.97, up 7%. Gross profit margin rose to 60.2%. The company narrowed its full-year sales outlook but raised gross margin and EPS expectations. Sales grew in all product categories and divisions, with sequential volume growth for four quarters. The company increased advertising by a double-digit percentage.

Original reporting
tradingview.com
Published Oct 30, 2026, 12:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 12:15 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Colgate-Palmolive Reports 4.6% Sales Growth and $0.97 Adjusted EPS — source image
Source · tradingview.com
Decision brief

The 30-second read

$CLBullishHigh
01

Why it matters

The earnings beat and raised guidance are likely to drive short‑term buying interest.

02

Market read

A large‑cap consumer staple with fresh earnings data; relevant for equity traders focusing on earnings catalysts.

03

What to watch

Potential cost pressures from raw‑material inflation could temper upside.

Relevance 9/10Novelty 9/10Timing: after‑hours release on Oct 30

Background

Colgate-Palmolive released its Q3 2026 earnings via an 8‑K filing, reporting sales growth and higher EPS.

Company-level read

Ticker impact

$CLBullishHigh confidence
Context

Colgate-Palmolive disclosed Q3 2026 net sales of $5.369 B (+4.6% YoY) and raised full‑year guidance, a fresh earnings release.

Expected impact

potential modest upside as market prices in the sales growth and higher guidance

Evidence & confidence

Revenue and EPS beat expectations; guidance lift typically supports the stock.

Market effects

Sector

Consumer staples may see modest lift as a large cap reports solid growth.

Regional

U.S. consumer‑goods sector gains support.

Global

Limited to consumer‑goods investors; no broad macro effect.

Counterpoint

What could challenge this read

If the market had already priced in strong demand, the guidance lift may be already reflected.

Key entities

  • company
    Colgate-Palmolive

    Consumer‑goods manufacturer reporting Q3 2026 results.

Read at source← All news

StoryColgate-Palmolive posts Q3 2026 beat and raises full‑year Base Business EPS outlook

Also covered by

4 outlets

Related articles

NOV 2
$CLMed

BofA raises Colgate-Palmolive stock price target to $105 on earnings

BofA Securities raised its price target for Colgate-Palmolive (NYSE:CL) to $105 from $100, citing strong earnings and updated fiscal 2026 guidance. The company reported Q3 earnings of $0.97 per share, exceeding estimates, with revenue of $5.37 billion. Colgate updated its outlook, expecting 4% to 5% net sales growth and 5% to 7% earnings growth. Analysts from UBS and Wells Fargo also raised their price targets.

investing.com2 min
NOV 2
$CLMedAI 8/10

Wells Fargo raises Colgate-Palmolive stock price target on solid Q3

Wells Fargo raised its price target for Colgate-Palmolive (NYSE:CL) to $95 from $90, citing solid Q3 2026 results. The firm noted strong performance despite macroeconomic challenges and inflation. CL's P/E ratio is 37.77, and it is considered overvalued. Q3 earnings beat expectations with $0.97 EPS on $5.37B revenue. UBS also raised its target to $112, highlighting strong margins.

investing.com2 min
NOV 2
$CLMed

UBS raises Colgate-Palmolive stock price target on margin strength

UBS raised its price target for Colgate-Palmolive (CL) to $112 from $106, citing strong Q3 earnings, revenue, and margins. The company beat EPS estimates and raised 2026 guidance. UBS expects continued sales growth despite inflation and FX headwinds, though the stock is slightly overvalued. CL reported Q3 adjusted EPS of $0.97 on revenue of $5.37B, exceeding expectations.

investing.com1 min
NOV 1
$CLMed

Colgate-Palmolive Co (CL) (Q3 2026) Earnings Call Highlights: Broad-Based Organic

Colgate-Palmolive (CL) reported Q3 2026 earnings, highlighting 6.5% organic growth in Hills pet food and strong volume leverage. CEO Noel Wallace attributed margin gains to pricing, innovation, and ad spend efficiency. CFO Stan Sutula noted material cost headwinds offset by productivity and pricing. Latin America grew 6%, with Brazil up double-digits. US toothpaste showed slight improvement, with more pricing expected.

finance.yahoo.com2 min
OCT 30
$CLHighAI 8/10

Colgate-Palmolive Company Q3 2026 Earnings Call Summary

Colgate-Palmolive reported Q3 2026 earnings, highlighting organic growth in emerging markets and Europe. Gross margin expansion was driven by pricing strategy and manufacturing leverage. The company is transitioning its U.S. go-to-market structure and integrating AI for revenue growth. Hill's Pet Nutrition saw strong performance in high-growth segments.

finance.yahoo.com3 min
OCT 30
$CLHighAI 8/10

Colgate-Palmolive Q3 Earnings Call Highlights

Colgate-Palmolive (CL) reported Q3 earnings, noting elevated commodity and logistics costs. Hill's Pet Nutrition saw 6.5% organic sales growth, driven by cat food and wet food. U.S. toothpaste market share shows early improvement. Latin America grew 6%, with Brazil up double digits. Asia-Pacific rose 5%, led by India. Full-year cost inflation is estimated at $300M. The company plans to provide 2027 guidance in Q1 next year.

finance.yahoo.com3 min